[go: up one dir, main page]

AU2001270678A1 - Vaccine against foot-and-mouth disease - Google Patents

Vaccine against foot-and-mouth disease

Info

Publication number
AU2001270678A1
AU2001270678A1 AU2001270678A AU7067801A AU2001270678A1 AU 2001270678 A1 AU2001270678 A1 AU 2001270678A1 AU 2001270678 A AU2001270678 A AU 2001270678A AU 7067801 A AU7067801 A AU 7067801A AU 2001270678 A1 AU2001270678 A1 AU 2001270678A1
Authority
AU
Australia
Prior art keywords
foot
vaccine against
mouth disease
against foot
mouth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270678A
Other languages
English (en)
Inventor
Jean-Christophe Audonnet
Alison Burman
Andrew King
Michel Lombard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Publication of AU2001270678A1 publication Critical patent/AU2001270678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AU2001270678A 2000-06-29 2001-06-27 Vaccine against foot-and-mouth disease Abandoned AU2001270678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008437 2000-06-29
FR0008437A FR2810888B1 (fr) 2000-06-29 2000-06-29 Vaccin contre la fievre aphteuse
PCT/FR2001/002042 WO2002000251A1 (fr) 2000-06-29 2001-06-27 Vaccin contre la fievre aphteuse

Publications (1)

Publication Number Publication Date
AU2001270678A1 true AU2001270678A1 (en) 2002-01-08

Family

ID=8851899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270678A Abandoned AU2001270678A1 (en) 2000-06-29 2001-06-27 Vaccine against foot-and-mouth disease

Country Status (13)

Country Link
US (1) US7531182B2 (fr)
EP (1) EP1294400B1 (fr)
JP (1) JP5153984B2 (fr)
CN (1) CN1440296B (fr)
AT (1) ATE552845T1 (fr)
AU (1) AU2001270678A1 (fr)
BR (1) BR0112071B1 (fr)
CY (1) CY1116491T1 (fr)
DK (1) DK1294400T3 (fr)
ES (1) ES2386373T3 (fr)
FR (1) FR2810888B1 (fr)
PT (1) PT1294400E (fr)
WO (1) WO2002000251A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2538486T3 (es) * 2002-09-12 2015-06-22 International Institute Of Cancer Immunology, Inc. Preparación de péptidos antigénicos contra el cáncer
CN1320116C (zh) * 2002-10-18 2007-06-06 中国人民解放军军需大学军事兽医研究所 O型口蹄疫病毒o_ny00株基因组序列
CN100381170C (zh) * 2003-09-03 2008-04-16 上海华谊生物技术有限公司 一种口蹄疫双价多肽疫苗及其制备方法和用途
CN1290579C (zh) * 2003-10-15 2006-12-20 北京迪威华宇生物技术有限公司 重组口蹄疫病毒vp1融合蛋白疫苗
CN100342911C (zh) * 2004-01-13 2007-10-17 厦门大学 A、o型口蹄疫病毒双价dna疫苗及其制备方法
US7527960B2 (en) * 2004-06-25 2009-05-05 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
CA2592366C (fr) * 2004-12-14 2013-11-19 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Vaccin recombine contre la fievre aphteuse
US9717788B2 (en) 2007-03-02 2017-08-01 Glaxosmithkline Biologicals Sa Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
RU2631129C1 (ru) * 2007-05-21 2017-09-19 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Способ изготовления вакцины против ящура и вакцина против ящура
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
CN101270155B (zh) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
GB0918375D0 (en) 2009-10-20 2009-12-02 Animal Health Inst Construct
EP2494051B1 (fr) * 2009-10-30 2016-03-09 Agresearch Limited Protéines d'encapsulation d'huile modifiée et utilisations de celles-ci
US8974834B2 (en) 2010-01-15 2015-03-10 Ecolab Usa Inc. Method for producing reservoir layer for hoof treatment and reservoir layer
EP2545067B1 (fr) * 2010-03-12 2016-11-30 Merial, Inc. Vaccins recombinants du virus de la fièvre catarrhale et leurs utilisations
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
CN101948811B (zh) * 2010-08-18 2013-01-09 中国农业科学院兰州兽医研究所 用反向遗传操作拓展口蹄疫疫苗株抗原谱及疫苗制备方法
GB201014965D0 (en) 2010-09-08 2010-10-20 Animal Health Inst Vaccine
US8906384B2 (en) * 2010-12-22 2014-12-09 The United States Of America As Represented By The Secretary Of Agriculture Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
CN103060278B (zh) * 2012-10-23 2014-07-09 于力 亚洲1型口蹄疫病毒耐酸突变株、其携带的衣壳蛋白及其编码基因和应用
RU2522868C1 (ru) * 2013-03-06 2014-07-20 Федеральное государственное унитарное предприятие "Щелковский биокомбинат" Способ изготовления вакцины против ящура
KR20210088754A (ko) 2013-03-15 2021-07-14 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 구제역 바이러스 (fmdv) 공통 단백질, 그에 대한 코딩 서열 및 그로부터 제조된 백신
NZ712410A (en) 2013-03-26 2020-01-31 The Pirbright Inst Stabilised fmdv capsids
KR101629353B1 (ko) * 2013-06-20 2016-06-15 대한민국 구제역 a형 표준 백신주의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101629345B1 (ko) * 2013-06-26 2016-06-15 대한민국 구제역 아시아1 혈청형 유전형 iv 바이러스의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101629282B1 (ko) * 2013-06-26 2016-06-15 대한민국 구제역 아시아1 혈청형 유전형 v 바이러스의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101578425B1 (ko) 2013-07-26 2015-12-18 대한민국 구제역 sat1형 wz 지역형의 방어항원이 발현되는 재조합 바이러스 및 그의 제조방법
RU2562547C1 (ru) * 2014-04-16 2015-09-10 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Вакцина инактивированная сорбированная против ящура типа а
AP2017009834A0 (en) * 2014-09-23 2017-03-31 Merial Inc Fmdv recombinant vaccines and uses thereof
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
CN105505853B (zh) * 2015-12-23 2019-03-15 中农威特生物科技股份有限公司 一种用于bhk-21细胞高密度悬浮培养的低血清培养基及其在口蹄疫病毒增殖中的应用
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
RU2617043C1 (ru) * 2016-03-24 2017-04-19 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" (ФГБНУ ВНИТИБП) Вакцина против ящура и способ её получения и применения
EP3675902A4 (fr) * 2017-08-28 2021-06-23 Board of Trustees of Michigan State University Compositions et méthodes de traitement du cancer et des infections à l'aide d'un bactériophage et de ses mutants
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN113817068B (zh) * 2020-12-24 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的o型口蹄疫疫苗
CN114957480B (zh) * 2021-02-23 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的a型口蹄疫疫苗
KR20240046569A (ko) 2021-08-20 2024-04-09 인터벳 인터내셔널 비.브이. 구제역 바이러스 바이러스-유사 입자의 생성 방법
WO2023020738A1 (fr) 2021-08-20 2023-02-23 The Pirbright Institute Particule pseudovirale de la fa à double mutation de stabilisation
CN117897170A (zh) 2021-08-20 2024-04-16 英特维特国际股份有限公司 具有稳定化突变的fmdv病毒样颗粒
EP4387661A1 (fr) 2021-08-20 2024-06-26 Intervet International B.V. Méthode de production d'une particule de type virus du virus de la fièvre aphteuse
KR20240055683A (ko) * 2022-10-19 2024-04-29 충남대학교산학협력단 구제역 바이러스 O형 캡시드 단백질 유래 단백질 및 sFc 단백질을 포함하는 재조합 단백질 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
ZA934890B (en) * 1992-07-08 1994-04-14 Schering Corp Use of Gm-CSF as a vaccine adjuvant
CA2214029A1 (fr) 1995-04-25 1996-10-31 Magda Marquet Formulations en ampoule unidose de complexes adn/lipides
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren

Also Published As

Publication number Publication date
EP1294400A1 (fr) 2003-03-26
US7531182B2 (en) 2009-05-12
EP1294400B1 (fr) 2012-04-11
FR2810888A1 (fr) 2002-01-04
US20040001864A1 (en) 2004-01-01
CN1440296B (zh) 2012-04-11
CN1440296A (zh) 2003-09-03
WO2002000251A1 (fr) 2002-01-03
DK1294400T3 (da) 2012-07-23
FR2810888B1 (fr) 2004-07-30
BR0112071B1 (pt) 2014-08-26
ATE552845T1 (de) 2012-04-15
ES2386373T3 (es) 2012-08-20
WO2002000251A9 (fr) 2002-04-04
JP5153984B2 (ja) 2013-02-27
CY1116491T1 (el) 2017-03-15
BR0112071A (pt) 2003-05-20
JP2004501874A (ja) 2004-01-22
PT1294400E (pt) 2012-07-10

Similar Documents

Publication Publication Date Title
AU2001270678A1 (en) Vaccine against foot-and-mouth disease
AP1872A (en) Virus-like particles of human papillomavirus.
Campo et al. Papillomavirus prophylactic vaccines: established successes, new approaches
AR022510A1 (es) Formulaciones de vacunas contra el papilomavirus humano
LU91392I2 (fr) "La particule viroïde de la protéine L1 recombinante du papillomavirus humain de type 16" - Cervarix
WO2001060847A3 (fr) Flavivirus chimeriques avirulents et immunogenes
WO2003048184A3 (fr) Vaccin a sous-unite de ns1 de flavivirus
NO2013003I2 (no) Forbindelser som NS3-serinproteaseinhibitorer for hepatitt C-virus, farmasøytiske preparater og anvendelse av forbindelsene til fremstilling av et medikament
BG106417A (en) Vaccine
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
WO2002024897A3 (fr) Vecteurs ameliores a replication conditionnelle, procedes de production et utilisation de ces vecteurs
AU2001275438A1 (en) Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
EP1420819A4 (fr) Vaccin sous-unite pour le virus de necrose pancreatique infectieux
WO2002078631A3 (fr) Vecteurs a replication conditionnelle ameliores destines a l'inhibition d'infections virales
CO5261595A1 (es) Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium
MXPA02003328A (es) Vacuna.
MXPA02012593A (es) Particulas de tipo virus del virus de la diarrea viral bovina.
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
CA2295316A1 (fr) Compositions renfermant des capsomeres de papillomavirus humain homogene, leurs procedes de production et leurs procedes d'utilisation en tant qu'agents diagnostiques, prophylactiques ou therapeutiques
TW200509964A (en) VP1 of foot-and-mouth disease virus
MX2007013472A (es) Vacuna.
UA95299C2 (ru) Профилактический или терапевтический агент против вирусного заболевания, вызванного вирусом гепатита с
CA2363493A1 (fr) Virus de la diarrhee virale bovine de formes attenuees
PT1194450E (pt) Vacina inactivada contra a calicivirose felina